Thomas Harrison - Director, Zynerba Pharmaceuticals, Inc

As of June 7, 2018


Thomas Harrison Net Worth

  • Net worth is estimated to be at least $10.32M
  • Owns at least 12,500 units of Zynerba Pharmaceuticals, Inc stock

Thomas Harrison Trading

  • Largest purchase of shares was 12,500 units , worth over $175K on August 12, 2015
  • In total has made about 8 transactions over 3 years
  • Usually trades in August, July and June, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Zynerba Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Armando Anido 2020 $585,265 $263,369 - $580,674 $53,441 $1,482,749
Armando Anido 2019 $568,218 $334,112 - $413,149 $54,092 $1,369,571
Terri B. Sebree 2020 $450,883 $209,660 - $428,858 $26,251 $1,115,652
Terri B. Sebree 2019 $437,750 $252,144 $13,140 $309,861 $25,985 $1,038,880
James E. 2020 $409,932 $129,129 - $303,775 $43,763 $886,599
James E. 2019 $390,411 $158,347 - $227,487 $47,862 $824,107
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1621443/000110465921052876/tm2111207-2_def14a.htm

Zynerba Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 5,000 units bought on August 22, 2018 by John Butler worth over $32.15K
  • In the last 3 years, insiders at Zynerba Pharmaceuticals, Inc sold an estimated value of $31.59K and bought an estimated value of $2.45M
  • The most active traders are Kenneth Moch, Director,  William Federici, Director,  and Armando Anido, Chairman & Chief Exec. Officer
  • Insider trading is most common in August, with the busiest year in 2018

Zynerba Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1